Brief intro on the company, Q&A appeared to be dominated by shareholders.. which is good to see.
Most interesting question was the last one on how close is CHM to another licensing agreement and whether or not they have enough cash to fund another one... I guess she indirectly answered it by saying they hope to be able to share some news on another assets "very shortly".
- Forums
- ASX - By Stock
- CHM
- Chimeric: Media Thread
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Chimeric: Media Thread, page-65
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $3.434K | 846.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4945717 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18563373 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4945717 | 0.004 |
41 | 27362937 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18563373 | 21 |
0.006 | 13884684 | 16 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 12.27pm 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online